1. Home
  2. DXR vs TELO Comparison

DXR vs TELO Comparison

Compare DXR & TELO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DXR
  • TELO
  • Stock Information
  • Founded
  • DXR 1970
  • TELO 2021
  • Country
  • DXR United States
  • TELO United States
  • Employees
  • DXR N/A
  • TELO N/A
  • Industry
  • DXR Medical/Dental Instruments
  • TELO
  • Sector
  • DXR Health Care
  • TELO
  • Exchange
  • DXR Nasdaq
  • TELO NYSE
  • Market Cap
  • DXR 46.1M
  • TELO 52.4M
  • IPO Year
  • DXR N/A
  • TELO 2024
  • Fundamental
  • Price
  • DXR $10.14
  • TELO $2.19
  • Analyst Decision
  • DXR Strong Buy
  • TELO
  • Analyst Count
  • DXR 1
  • TELO 0
  • Target Price
  • DXR $25.00
  • TELO N/A
  • AVG Volume (30 Days)
  • DXR 3.2K
  • TELO 9.2M
  • Earning Date
  • DXR 01-01-0001
  • TELO 08-12-2025
  • Dividend Yield
  • DXR N/A
  • TELO N/A
  • EPS Growth
  • DXR 86.16
  • TELO N/A
  • EPS
  • DXR 0.11
  • TELO N/A
  • Revenue
  • DXR $119,714.00
  • TELO N/A
  • Revenue This Year
  • DXR N/A
  • TELO N/A
  • Revenue Next Year
  • DXR N/A
  • TELO N/A
  • P/E Ratio
  • DXR $92.00
  • TELO N/A
  • Revenue Growth
  • DXR N/A
  • TELO N/A
  • 52 Week Low
  • DXR $6.55
  • TELO $1.12
  • 52 Week High
  • DXR $10.23
  • TELO $8.40
  • Technical
  • Relative Strength Index (RSI)
  • DXR 65.31
  • TELO 64.07
  • Support Level
  • DXR $9.05
  • TELO $2.00
  • Resistance Level
  • DXR $9.90
  • TELO $2.44
  • Average True Range (ATR)
  • DXR 0.29
  • TELO 0.19
  • MACD
  • DXR 0.02
  • TELO 0.15
  • Stochastic Oscillator
  • DXR 100.00
  • TELO 54.04

About DXR Daxor Corporation

Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.

About TELO TELOMIR PHARMACEUTICALS INC

Telomir Pharmaceuticals Inc is a pioneering preclinical-stage pharmaceutical company which leads the advancement of age-reversal science. The Company is focused on developing Telomir-1, a novel small molecule designed to lengthen and protect telomeres-the protective DNA end caps of chromosomes that are crucial to cellular aging. As humans and animals age, telomeres naturally shorten, with metal reactivity accelerating this process, increasing the risk of degenerative and age-related diseases. By addressing the underlying causes of aging at the cellular level, Telomir aims to tackle the root of these conditions rather than simply treating their symptoms. Telomir is conducting ongoing preclinical research into Progeria, diabetes, cancer, Alzheimer's disease, osteoarthritis, and others.

Share on Social Networks: